Created at Source Raw Value Validated value
June 25, 2024, noon usa

1. having symptoms compatible with covid-19 2. diagnosed hiv infection 3. current use of pre-exposure prophylaxis for hiv 4. diagnosed hepatitis b infection. 5. diagnosed renal insufficiency and or current hemodialysis need 6. diagnosed osteoporosis under pharmacological treatment. 7. weight \< 40kg 8. current immunosuppressive or serious hematological condition 9. prior use of pre-exposure prophylaxis for sars-cov-2 10. current pregnancy or pregnancy plan within the study course. 11. current breastfeeding 12. known hypersensitivity to any of the study medication components.

1. having symptoms compatible with covid-19 2. diagnosed hiv infection 3. current use of pre-exposure prophylaxis for hiv 4. diagnosed hepatitis b infection. 5. diagnosed renal insufficiency and or current hemodialysis need 6. diagnosed osteoporosis under pharmacological treatment. 7. weight \< 40kg 8. current immunosuppressive or serious hematological condition 9. prior use of pre-exposure prophylaxis for sars-cov-2 10. current pregnancy or pregnancy plan within the study course. 11. current breastfeeding 12. known hypersensitivity to any of the study medication components.

Nov. 16, 2021, 6:30 p.m. usa

having symptoms compatible with covid-19 diagnosed hiv infection current use of pre-exposure prophylaxis for hiv diagnosed hepatitis b infection. diagnosed renal insufficiency and or current hemodialysis need diagnosed osteoporosis under pharmacological treatment. weight < 40kg current immunosuppressive or serious hematological condition prior use of pre-exposure prophylaxis for sars-cov-2 current pregnancy or pregnancy plan within the study course. current breastfeeding known hypersensitivity to any of the study medication components.

having symptoms compatible with covid-19 diagnosed hiv infection current use of pre-exposure prophylaxis for hiv diagnosed hepatitis b infection. diagnosed renal insufficiency and or current hemodialysis need diagnosed osteoporosis under pharmacological treatment. weight < 40kg current immunosuppressive or serious hematological condition prior use of pre-exposure prophylaxis for sars-cov-2 current pregnancy or pregnancy plan within the study course. current breastfeeding known hypersensitivity to any of the study medication components.

Oct. 26, 2020, 11:31 p.m. usa

1. having symptoms compatible with covid-19 2. diagnosed hiv infection 3. current use of pre-exposure prophylaxis for hiv 4. diagnosed hepatitis b infection. 5. diagnosed renal insufficiency and or current hemodialysis need 6. diagnosed osteoporosis under pharmacological treatment. 7. weight < 40kg 8. current immunosuppressive or serious hematological condition 9. prior use of pre-exposure prophylaxis for sars-cov-2 10. current pregnancy or pregnancy plan within the study course. 11. current breastfeeding 12. known hypersensitivity to any of the study medication components.

1. having symptoms compatible with covid-19 2. diagnosed hiv infection 3. current use of pre-exposure prophylaxis for hiv 4. diagnosed hepatitis b infection. 5. diagnosed renal insufficiency and or current hemodialysis need 6. diagnosed osteoporosis under pharmacological treatment. 7. weight < 40kg 8. current immunosuppressive or serious hematological condition 9. prior use of pre-exposure prophylaxis for sars-cov-2 10. current pregnancy or pregnancy plan within the study course. 11. current breastfeeding 12. known hypersensitivity to any of the study medication components.